Home > Healthcare > Thyroid Cancer Diagnostics Market > Table of Contents

Thyroid Cancer Diagnostics Market Size – By Product (Instruments, Kits and Consumables), Type (Papillary Carcinoma, Follicular Carcinoma), Technique (Blood Test, Imaging, Biopsy), End-use (Hospitals, Cancer Diagnostic Centers) & Forecast, 2024 – 2032

  • Report ID: GMI9403
  • Published Date: May 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Research design

1.2.1    Research approach

1.2.2    Data collection methods

1.3    Base estimates & calculations

1.3.1    Base year calculation

1.3.2    Key trends for market estimation

1.4    Forecast model

1.5    Primary research and validation

1.5.1    Primary sources

1.5.2    Data mining sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1   Increasing prevalence of thyroid cancer

3.2.1.2   Advancement in cancer diagnostic technologies

3.2.1.3   Growing awareness through screening programs

3.2.2    Industry pitfalls & challenges

3.2.2.1   Stringent regulatory scenario

3.2.2.2   High cost of thyroid cancer diagnosis

3.3    Growth potential analysis

3.4    Technological landscape

3.5    Regulatory landscape

3.6    Future market trends

3.7    Porter’s analysis

3.8    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company market share analysis

4.3    Competitive analysis of major market players

4.4    Competitive positioning matrix

4.5    Strategy outlook matrix

Chapter 5   Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)

5.1    Key trends

5.2    Instruments

5.3    Kits and consumables

Chapter 6   Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)

6.1    Key trends

6.2    Papillary carcinoma

6.3    Follicular carcinoma

6.4    Other types

Chapter 7   Market Estimates and Forecast, By Technique, 2021 – 2032 ($ Mn)

7.1    Key trends

7.2    Blood test

7.3    Imaging

7.4    Biopsy

7.5    Other techniques

Chapter 8   Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)

8.1    Key trends

8.2    Hospitals

8.3    Cancer diagnostic centers

8.4    Academic and research institutes

8.5    Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)

9.1    Key trends

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Netherlands

9.3.7    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    South Korea

9.4.6    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Argentina

9.5.4    Rest of Latin America

9.6    Middle East and Africa

9.6.1    Saudi Arabia

9.6.2    South Africa

9.6.3    UAE

9.6.4    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Abbott Laboratories

10.2    Agilent Technologies, Inc.

10.3    Bio-Rad Laboratories, Inc.

10.4    Canon Inc.

10.5    Danaher Corporation

10.6    Esaote SPA

10.7    F. Hoffmann-La Roche Ltd

10.8    GE HealthCare

10.9    Hologic, Inc.

10.10    Illumina, Inc.

10.11    Koninklijke Philips N.V.

10.12    PerkinElmer, Inc.

10.13    Siemens Healthineers AG

10.14    Thermo Fisher Scientific Inc.

10.15    Veracyte, Inc.
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 272
  • Countries covered: 23
  • Pages: 198
 Download Free Sample